(Q46922662)

26 December 2017

title

Plasma homocysteine and severe white matter disease (English)

1 reference

26 December 2017

author name string

B Censori

1

1 reference

26 December 2017

T Partziguian

2

1 reference

26 December 2017

O Manara

3

1 reference

26 December 2017

M Poloni

4

1 reference

26 December 2017

publication date

31 October 2007

1 reference

26 December 2017

published in

Neurological Sciences

1 reference

26 December 2017

volume

28

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

page(s)

259-263

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s10072-007-0832-y

exact match

0 references

cites work

Pathogenesis of leukoaraiosis: a review

1 reference

https://api.crossref.org/works/10.1007%2FS10072-007-0832-Y

Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-007-0832-Y

A new rating scale for age-related white matter changes applicable to MRI and CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-007-0832-Y

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-007-0832-Y

Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-007-0832-Y

Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study.

21 January 2018

1 reference

12 December 2020

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

1 reference

12 December 2020

Homocysteine and stroke

1 reference

12 December 2020

Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease

1 reference

12 December 2020

Changes in plasma homocyst(e)ine in the acute phase after stroke

1 reference

12 December 2020

Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study

1 reference

12 December 2020

Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study

1 reference

12 December 2020

Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men.

1 reference

12 December 2020

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease

1 reference

12 December 2020

Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia

1 reference

12 December 2020

A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.

1 reference

12 December 2020

Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study

1 reference

12 December 2020

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

12 December 2020

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

12 December 2020

Homocysteine in cerebral macroangiography and microangiopathy

1 reference

12 December 2020

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

1 reference

12 December 2020

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

1 reference

12 December 2020

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

1 reference

12 December 2020

Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction

1 reference

12 December 2020

Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases.

1 reference

12 December 2020

Homocysteine, white matter hyperintensities, and cognition in healthy elderly people

1 reference

12 December 2020

Homocysteine and atherothrombosis

1 reference

12 December 2020

Impaired homocysteine metabolism and atherothrombotic disease

1 reference

12 December 2020

The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke

1 reference

12 December 2020

Homocysteine metabolism and the oxidative modification of proteins and lipids

1 reference

12 December 2020

10.1007/S10072-007-0832-Y

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

17972040

1 reference

26 December 2017